Clinical Trials Browser

Interventional × Protein Subunit Vaccines × CNS × Clear all

NCT02754362 2020-01-13

A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma

Phase 2 Withdrawn

Glioblastoma, Glioma

NCT00874861 2015-12-08

HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas

Phase EARLY_PHASE1 Completed

Astrocytoma, Neoplasms, Oligodendroglioma